Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Adamson

Showing results (241-250 of 342) with videos related to

Pageof 35
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancerM A Smith, P C Adamson, F M Balis, et al.
Journal of Clinical Pharmacology|October 22, 2005
Drug utilization in the pediatric intensive care unit: monitoring prescribing trends and establishing prioritization of pharmacotherapeutic evaluation of critically ill childrenAthena F Zuppa, Peter C Adamson, John T Mondick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumorsK E Warren, J A Frank, J L Black, et al.
The Journal of Nutrition|June 4, 2021
Macular Xanthophylls and Markers of the Anterior Visual Pathway among Persons with Multiple SclerosisJonathan Cerna, Nikta S Athari Anaraki, Connor M Robbs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2012
Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium studyYael P Mossé, Emily Lipsitz, Elizabeth Fox, et al.
Pediatric Blood & Cancer|September 23, 2010
Phase 1 trial and pharmacokinetic study of the farnesyl transferase inhibitor tipifarnib in children and adolescents with refractory leukemias: a report from the Children's Oncology GroupBrigitte C Widemann, Robert J Arceci, Nalini Jayaprakash, et al.
Pediatric Blood & Cancer|July 1, 2010
Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: a Children's Oncology Group studyRani E George, Jill M Lahti, Peter C Adamson, et al.
Cancer Research|August 1, 1990
Pediatric phase I trial and pharmacokinetic study of piritrexim administered orally on a five-day scheduleP C Adamson, F M Balis, J Miser, et al.
Pediatric Blood & Cancer|July 27, 2010
A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group studyOrren Beaty, Stacey Berg, Susan Blaney, et al.
Journal of the National Cancer Institute|April 5, 2017
Target and Agent Prioritization for the Children's Oncology Group-National Cancer Institute Pediatric MATCH TrialCarl E Allen, Theodore W Laetsch, Rajen Mody, et al.
Pageof 35

Showing results (241-250 of 342) with videos related to

Sort By:
Pageof 35
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancerM A Smith, P C Adamson, F M Balis, et al.
Journal of Clinical Pharmacology|October 22, 2005
Drug utilization in the pediatric intensive care unit: monitoring prescribing trends and establishing prioritization of pharmacotherapeutic evaluation of critically ill childrenAthena F Zuppa, Peter C Adamson, John T Mondick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumorsK E Warren, J A Frank, J L Black, et al.
The Journal of Nutrition|June 4, 2021
Macular Xanthophylls and Markers of the Anterior Visual Pathway among Persons with Multiple SclerosisJonathan Cerna, Nikta S Athari Anaraki, Connor M Robbs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2012
Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium studyYael P Mossé, Emily Lipsitz, Elizabeth Fox, et al.
Pediatric Blood & Cancer|September 23, 2010
Phase 1 trial and pharmacokinetic study of the farnesyl transferase inhibitor tipifarnib in children and adolescents with refractory leukemias: a report from the Children's Oncology GroupBrigitte C Widemann, Robert J Arceci, Nalini Jayaprakash, et al.
Pediatric Blood & Cancer|July 1, 2010
Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: a Children's Oncology Group studyRani E George, Jill M Lahti, Peter C Adamson, et al.
Cancer Research|August 1, 1990
Pediatric phase I trial and pharmacokinetic study of piritrexim administered orally on a five-day scheduleP C Adamson, F M Balis, J Miser, et al.
Pediatric Blood & Cancer|July 27, 2010
A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group studyOrren Beaty, Stacey Berg, Susan Blaney, et al.
Journal of the National Cancer Institute|April 5, 2017
Target and Agent Prioritization for the Children's Oncology Group-National Cancer Institute Pediatric MATCH TrialCarl E Allen, Theodore W Laetsch, Rajen Mody, et al.
Pageof 35